ArticleNeurology and therapy2026

Rapid Serum IgG Reduction as a Potential Indicator of Short-Term Clinical Improvement in AChR-Ab-Positive Generalized Myasthenia Gravis: A Post Hoc Analysis of a Phase III Batoclimab Trial.

Zhijun Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.